Skip to main content
The Lancet Regional Health - Europe logoLink to The Lancet Regional Health - Europe
. 2026 Jul 23;67:101793. doi: 10.1016/j.lanepe.2026.101793

Corrigendum to ‘Metabolic trajectories before diabetes diagnosis across subgroups: a pooled analysis of prospective European cohort studies’ [The Lancet Regional Health—Europe volume 66 (2026) 1–11/101715]

Liisa Hakaste a,b,∗, Mette K Andersen c, Lars Ängquist c, Haifa Maalmi d,e, Jagadish Vangipurapu f,g, Türküler Cakmak h, Anna Möllsten i, Björn Tavelin j, Mikko Lehtovirta b, Most Champa Begum k, Rashmi B Prasad l, Annette Peters m,n,o,p, Barbara Thorand m,n,o, Allan Linneberg q,r, Markku Laakso f, Olov Rolandsson i, Bjørn Olav Åsvold s,t, Valeriya Lyssenko k,l, Peter M Nilsson l, Christian Herder d,e,u, Michael Roden d,e,u, Torben Hansen c, Emma Ahlqvist l,∗∗,w, Tiinamaija Tuomi a,b,l,v,∗∗∗,w
PMCID: PMC13416620  PMID: 42529288

The authors regret HOMA2-IR is reported as 67% in the Results but 50% in the Discussion; the correct effect size is 67%.

The authors would like to apologise for any inconvenience caused.

Contributor Information

Liisa Hakaste, Email: liisa.hakaste@hus.fi, liisa.hakaste@helsinki.fi.

Emma Ahlqvist, Email: emma.ahlqvist@med.lu.se.

Tiinamaija Tuomi, Email: tiinamaija.tuomi@hus.fi.


Articles from The Lancet Regional Health - Europe are provided here courtesy of Elsevier

RESOURCES